BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LIMITED

Altre lingue Bharat Immunologicals & Biologicals Corporation Limited

Azioni

BIBCL6

INE994B01014

Tempo differito Bombay S.E. Altri mercati azionari 10:37:30 11/07/2024			Variaz. 5gg	Var. 1 gen.
28,48 ^INR	-0,42%		-2,03%	-19,43%

2023	Bharat Immunologicals & Biologicals Corporation Limited riporta i risultati degli utili per il secondo trimestre e i sei mesi conclusi il 30 settembre 2023	CI
2023	Bharat Immunologicals & Biologicals Corporation Limited riporta i risultati degli utili per il primo trimestre conclusosi il 30 giugno 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	01/11
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	01/11
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Full Year Ended March 31, 2023	31/05/23
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	10/02/23
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	17/10/22
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	15/08/22
EU countries agree to admit travellers vaccinated with WHO-approved shots	22/02/22
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Third Quarter Ended December 31, 2021	09/02/22
EU proposes booster jabs for 2022 travel, opens to WHO vaccines	25/11/21
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Second Quarter Ended September 30, 2021	30/10/21
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	27/07/21
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Full Year Ended March 31, 2021	30/06/21
Bharat Immunologicals & Biologicals : to Receive Indian Government Funding for COVID Vaccine Production	19/04/21
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	11/02/21
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	30/12/20
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Full Year Ended March 31, 2020	31/07/20
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019	31/01/20
Bharat Immunologicals & Biologicals Corp. Ltd. Reports Earnings Results for the Second Quarter Ended September 30, 2019	30/10/19
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the First Quarter Ended June 30, 2019	01/08/19
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2019	11/04/19

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Bharat Immunologicals & Biologicals Corporation Limited

Azioni

BIBCL6

INE994B01014

Altre lingue

Filtri